Quotient Sciences AI Algorithm Hits Pharmacokinetic Target Within Three Dosing Periods

Quotient Sciences, a global integrated CRDMO (contract research, development and manufacturing organization), reported interim results from a clinical st...

September 23, 2026 | Wednesday | News
NorahLux Launches Research Hub Covering More Than 10,000 Red Light Therapy Studies

NorahLux has launched the Red Light Therapy Research Hub, an interactive research tool designed to make studies on photobiomodulation easier to search an...

September 22, 2026 | Tuesday | News
Teva Reports Real-World Data Showing UZEDY Supports Treatment Continuity and Reduces Healthcare Utilization in Schizophrenia

Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd.  announced new real-world data evaluating treatment continuity, health...

September 21, 2026 | Monday | News
Samsung Biologics Announced CHF 1.46 Billion Tender Offer to Acquire PolyPeptide

  Samsung Biologics to launch an all-cash public tender offer for 100% of PolyPeptide's fully diluted share capital (excluding ...

July 21, 2026 | Tuesday | News
CellCarta Launched Global Digital Pathology and AI Consortium for Precision Medicine

Consortium initially brings together Lunit, Mindpeak, Imagene AI, Dipath AI, Nucleai, Tivenix and Indica Labs to give biopharma sponsors a single CRO-led...

July 17, 2026 | Friday | News
SK bioscience to Lead Gates Foundation-Funded AI Project to Transform Vaccine Clinical Development

SK bioscience was selected to lead the Gates Foundation-funded ROTOR project, establishing a global collaboration framework. SK bioscience, PATH, Slal...

July 07, 2026 | Tuesday | News
Redefining Biologics Partnerships Through Shared Risk and Scientific Collaboration

The biologics development landscape is becoming increasingly complex, requiring partners that offer more than manufacturing capacity alone. As biotech comp...

June 22, 2026 | Monday | Expert Opinion
Novo Nordisk Foundation Launches €60 Million European Initiative to Accelerate Cardiometabolic Drug Discovery

The Novo Nordisk Foundation is funding a new pan-European initiative to accelerate drug discovery and the development of next generation therapeutics for...

June 22, 2026 | Monday | News
Avance Clinical Expands APAC and China Operations to Strengthen Global Biotech Trial Support

Avance Clinical, the Australian-headquartered global Contract Research Organization (CRO) for biotechs, announced a significant expansion of its Asia Pac...

June 22, 2026 | Monday | News
From Outsourcing to Strategic Alignment: The Future of CRO Partnerships in Biotech Building CRO Partnerships That Drive Speed, Continuity, and Clinical Success

As clinical development grows more complex and globally interconnected, biotech companies are under increasing pressure to build CRO partnerships that deli...

May 15, 2026 | Friday | Interaction
Neurizon Therapeutics Receives HREC Approval for Phase 1 Study of NUZ-001 Oral Liquid Formulation in ALS

 Neurizon® Therapeutics Limited (ASX: NUZ & NUZOA; OTCQB: NUZTF) (“Neurizon” or “the Company”), is pleased to announ...

May 15, 2026 | Friday | News
GI Partners Completes Acquisition of Charles River’s CDMO and Cell Solutions Businesses, Launches Rose BioSolutions

Creates Standalone Leader in Advanced Therapy Manufacturing with Decades of Proven Experience and Continued Commitment to Client Service Dedicated Resou...

May 11, 2026 | Monday | News
WuXi Biologics Secures South Korea MFDS GMP Certification for Three Wuxi Facilities

 WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), announced that three of its manu...

April 24, 2026 | Friday | News
Crown Bioscience Partners with Turbine to Advance Translational Oncology with Integrated In Silico and Organoid Platforms

 Crown Bioscience, a global contract research organization (CRO) and a JSR Life Sciences company, announced a strategic partnership with Turbine, a ...

April 23, 2026 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close